Agio Pharmaceuticals Limited — Secnidazole Exporter Profile
Indian Pharmaceutical Exporter · #14 for Secnidazole · $150.7K export value · DGFT Verified
Agio Pharmaceuticals Limited is the #14 Indian exporter of Secnidazole with $150.7K in export value and 12 verified shipments. Agio Pharmaceuticals Limited holds a 0.5% market share in Secnidazole exports across 2 countries. The company exports 15 pharmaceutical products worth $11.9M across 8 therapeutic categories.
Agio Pharmaceuticals Limited — Secnidazole Export Profile: Buyers & Destinations
Where Does Agio Pharmaceuticals Limited Export Secnidazole?
Agio Pharmaceuticals Limited exports Secnidazole to 2 countries. The largest destination is KENYA accounting for 63.9% of Agio Pharmaceuticals Limited's Secnidazole shipments. These destinations reflect Agio Pharmaceuticals Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Secnidazole from Agio Pharmaceuticals Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| TO THE ORDER OF | KENYA | $65.5K | 2 |
| ROYAL PHARMA 2011 LIMITED | UGANDA | $65.1K | 8 |
| TO THE ORDER OF SYNERMED | KENYA | $20.1K | 2 |
Agio Pharmaceuticals Limited supplies Secnidazole to 3 buyers globally. The largest buyer is TO THE ORDER OF (KENYA), followed by ROYAL PHARMA 2011 LIMITED (UGANDA) and TO THE ORDER OF SYNERMED (KENYA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Secnidazole Export Value and How Much Does Agio Pharmaceuticals Limited Contribute?
India exported $8.9M worth of Secnidazole through 652 shipments from 115 suppliers to 77 countries, serving 239 buyers globally. Agio Pharmaceuticals Limited contributes $150.7K to this total, accounting for 0.5% of India's Secnidazole exports. Agio Pharmaceuticals Limited ships Secnidazole to 2 countries through 3 buyers.
What Is the Average Shipment Value for Agio Pharmaceuticals Limited's Secnidazole Exports?
Agio Pharmaceuticals Limited's average Secnidazole shipment value is $12.6K per consignment, based on 12 shipments totaling $150.7K. The largest destination is KENYA (63.9% of Agio Pharmaceuticals Limited's Secnidazole exports).
How Does Agio Pharmaceuticals Limited Compare to Other Indian Secnidazole Exporters?
Agio Pharmaceuticals Limited ranks #14 among 115 Indian Secnidazole exporters with a 0.5% market share. The top 3 exporters are CAPLIN POINT LABORATORIES LIMITED ($2.1M), AJANTA PHARMA LIMITED ($2.0M), LINCOLN PHARMACEUTICALS LTD ($950.0K). Agio Pharmaceuticals Limited processed 12 shipments to 2 destination countries.
What Secnidazole Formulations Does Agio Pharmaceuticals Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| AGISEC 1 GM SECNIDAZOLE TABLETS 1 G | $65.5K | 2 |
| AGISEC 1GM (SECNIDAZOLE TABLETS) | $43.6K | 4 |
| AGISEC 1 GM (SECNIDAZOLE TABLETS 1 G) | $13.4K | 1 |
| AGISEC 1GM SECNIDAZOLE TABLETS 1 G | $10.8K | 1 |
| AGISEC 1GM (SECNIDAZOLE TABLETS 1 G) | $10.7K | 3 |
| AGISEC 1 GM (SECNIDAZOLE TABLETS 1 G) | $6.6K | 1 |
Agio Pharmaceuticals Limited exports 6 distinct Secnidazole formulations including tablets, capsules, syrups, and combination drugs. The top formulation is AGISEC 1 GM SECNIDAZOLE TABLETS 1 G with 2 shipments worth $65.5K.
How Does Agio Pharmaceuticals Limited Compare to Nearest Secnidazole Exporters?
Exporters ranked immediately above and below #14 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 12 | ALICE PHARMA PRIVATE LIMITED | $187.1K | 11 | 2 | $17.0K |
| 13 | TRIDENT LIFELINE LIMITED | $152.5K | 10 | 2 | $15.2K |
| 14 | AGIO PHARMACEUTICALS LIMITED ★ | $150.7K | 12 | 2 | $12.6K |
| 15 | STRIDES PHARMA SCIENCE LIMITED | $115.2K | 3 | 1 | $38.4K |
Agio Pharmaceuticals Limited ranks #14 among 115 Indian Secnidazole exporters. Average shipment value of $12.6K compared to the market average of $77.0K. The closest competitors by value are ALICE PHARMA PRIVATE LIMITED and TRIDENT LIFELINE LIMITED.
Which Indian Ports Ship Secnidazole Exports?
| Port | Shipments | % Share |
|---|---|---|
| NHAVA SHEVA SEA (INNSA1) | 75 | 11.5% |
| SAHAR AIR | 59 | 9.0% |
| SAHAR AIR CARGO ACC (INBOM4) | 57 | 8.7% |
| JNPT/ NHAVA SHEVA SEA | 46 | 7.1% |
| DELHI AIR | 46 | 7.1% |
| JNPT | 34 | 5.2% |
| DELHI AIR CARGO ACC (INDEL4) | 31 | 4.8% |
| AHEMDABAD ICD | 22 | 3.4% |
Geopolitical & Trade Policy Impact on Agio Pharmaceuticals Limited's Secnidazole Exports
Recent geopolitical developments have introduced complexities into the pharmaceutical export landscape. The Israel-Iran conflict has led to disruptions in Red Sea shipping routes, causing increased freight charges and potential losses for Indian exporters. According to Pharmaceutical Commerce, maritime carriers' booking suspensions and diversions around the Cape of Good Hope are elongating lead times and pressurizing Suez-linked lanes, disproportionately impacting time-sensitive pharmaceutical replenishment cycles. This situation poses challenges for Agio Pharmaceuticals, particularly in maintaining timely deliveries to key markets.
In the United States, recent tariff implementations have affected a significant portion of Indian exports. The Federation of Indian Export Organisations highlighted that the latest U.S. tariffs impact nearly 55% of India's outbound shipments to America, placing Indian exporters at a competitive disadvantage. For Agio, which relies on the U.S. market, these tariffs could necessitate strategic adjustments to pricing and supply chain logistics.
The European Union's stringent regulatory changes, including the Falsified Medicines Directive, demand enhanced compliance measures from exporters. Agio's ability to adapt to these evolving standards will be crucial in sustaining its market presence in the EU.
Agio Pharmaceuticals Limited — Regulatory Compliance & Quality Standards
The global pharmaceutical industry is witnessing heightened regulatory scrutiny, with agencies like the U.S. FDA increasing inspections of manufacturing facilities. India, hosting over 600 US FDA-approved sites, faces challenges in maintaining compliance. The US FDA conducted more than 200 inspections in 2023, with plans to increase this number in 2024. For Agio Pharmaceuticals, ensuring adherence to Good Manufacturing Practices (GMP) and other quality standards is imperative to avoid potential export bans or reputational damage.
Additionally, the prevalence of counterfeit drugs has raised concerns about India's reputation as a reliable supplier. Agio must implement robust quality control systems and transparent governance to navigate this landscape effectively.
About Agio Pharmaceuticals Limited
Agio Pharmaceuticals Limited exports 15 products worth $11.9M. Beyond Secnidazole, top products include Dexamethasone, Phenylephrine, Clotrimazole, Prednisolone, Salbutamol. View the complete Agio Pharmaceuticals Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Secnidazole — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Secnidazole shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Agio Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 12 individual customs records matching Agio Pharmaceuticals Limited exporting Secnidazole, covering 6 formulations to 2 countries via 3 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 77+ countries, 239+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Secnidazole Export Data from Agio Pharmaceuticals Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Agio Pharmaceuticals Limited's Secnidazole exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Agio Pharmaceuticals Limited
Full Company Profile →
15 products · $11.9M total trade · 8 categories
Secnidazole Stats
Company Overview
Top Products by Agio Pharmaceuticals Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Agio Pharmaceuticals Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Secnidazole. For current shipment-level data, contact TransData Nexus.